Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank64
3Y CAGR+7.1%
5Y CAGR+10.4%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+7.1%/yr
vs +32.6%/yr prior
5Y CAGR
+10.4%/yr
Recent deceleration
Acceleration
-25.5pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.66 | +36.4% |
| 2023 | 1.22 | +114.3% |
| 2022 | 0.57 | -58.0% |
| 2021 | 1.35 | +242.6% |
| 2020 | 0.40 | -61.0% |
| 2019 | 1.01 | +110.5% |
| 2018 | 0.48 | +9.9% |
| 2017 | 0.44 | -67.3% |
| 2016 | 1.34 | -44.8% |
| 2015 | 2.43 | - |